Gene Query: LMNB1

Dataset Description Geneva Score
Genome-wide transcriptional response to random aneuploidy in human cells 129.73
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 118.21
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 94.74
MYCi361 regulates MYC target genes 93.79
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 92.74
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 84.94
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 84.94
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 83.3
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 79.71
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 79.71
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 79.66
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 76.43
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 72.75
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 65.17
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 62.92
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 62.62
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 61.52
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 60.51
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 59.8
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 59.8
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 58.46
FOXD3 is a novel tumor suppressor in lung cancer 58.31
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 57.19
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 56.79
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 54.31
Conservative alteration of chromosomal expression pattern across human solid tumor types 53.65
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 52.02
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 51.49
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 51.06
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 51.06
Paxillin regulates genomic networks in prostate cancer [LNCaP] 50.17
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 50.14
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 50.14
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 48.98
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 48.97
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 48.31
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 47.29
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 47.1
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 46.85
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 45.17
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 45.16
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 45.04
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 44.59
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 43.82
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 43.13
Gene expression in PANC1 cells treated with Rakicidin 43.05
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 42.86
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 42.83
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 42.8
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 42.8
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 42.79
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 42.7
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 42.5
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 40.52
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 39.95
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 39.94
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 39.76
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 39.65
Expression level comparison under dividing and quiescent states in human primary fibroblasts 38.94
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 38.92
RNA-seq analysis to identify the genes regulated by p53-SET interplay 38.86
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 38.64
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 38.13
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 38.08
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 38.04
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 37.26
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 36.78
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 36.49
RNA-seq of shEZH2 cells 36.22
A code of mono-phosphorylation modulates the function of RB. 35.81
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 35.74
Transcriptional profiles of normal human mature B cells 35.38
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 34.95
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 34.95
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 34.45
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 34.35
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 34.22
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 33.67
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 33.67
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 33.56
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 32.75
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 32.15
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 32.11
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 32.09
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 32.09
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 32.09
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 32.03
MCF10A H-Ras RNA-Seq 31.75
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 31.51
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 31.49
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 31.38
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 31.38
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 31.18
The landscape of alternative splicing in aggressive prostate cancers 31.18
Landscape of H3K4me3 in human CD19 cells 31.14
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 30.91
Gene expression changes caused by KRAS in MCF-10A 30.89
Expression profiling of etoposide-induced senescent cells 30.51
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 30.26
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 30.14
Aneuploidy triggers an immune response 29.71
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 29.47
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 29.38
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 29.24
Neurofibroma 29.2
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 29.2
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 29.03
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 28.98
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 28.95
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 28.41
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 28.29
Transcriptomic profiling of human peripheral blood-derived mast cells 28.09
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 28.09
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 27.93
A sister of NANOG regulates genes expressed in pre-implantation human development 27.92
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 27.89
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 27.88
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 27.85
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 27.82
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 27.8
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 27.8
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 27.8
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 27.64
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 27.62
High level DNA repair gene expression in human ES cells 27.61
Maturation of human iNSCs 27.56
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 27.3
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 27.23
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 27.21
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 27.16
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 27.16
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 27.1
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 27.01
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 26.85
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 26.85
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 26.84
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 26.82
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 26.82
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 26.82
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 26.55
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 26.55
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 26.53
Effects of rFVIIIFc on human macrophages 26.49
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 26.41
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 26.32
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 26.19
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 26.07
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 26.04
G-quadruplex structures mark human regulatory chromatin 25.99
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 25.87
Effect of Influenza virus infection on lncRNA expression in A549 cells 25.78
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 25.68
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 25.17
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 25.16
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 24.98
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 24.6
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 24.53
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 24.34
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 24.27
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 24.27
Differentially expressed vascular development genes for iPSC-ECs from CDI 24.15
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 24.02
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 23.98
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 23.96
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 23.94
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 23.87
A549 cells and MSR-A549 cells 23.87
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 23.87
Widespread intronic polyadenylation diversifies immune cell transcriptomes 23.8
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 23.7
Role for citron kinase in prostate cancer growth 23.7
LncRNA-GAS5 negative regulation of YAP-target genes expression 23.38
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 23.27
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 23.27
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 23.16
Novel Targeting of Transcription and Metabolism in Glioblastoma 23.12
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 23.11
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 23.08
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 22.86
Chromatin landscape of human visceral and subcutaneous adipocytes 22.83
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 22.82
Identification of HOXB13 target genes responsive to BET inhibitors 22.78
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 22.76
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 22.76
RNA-seq of resting and activated CD4+ T cells +-JQ1 22.71
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 22.51
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 22.43
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 22.43
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 22.34
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 22.26
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 22.26
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 22.13
mRNA-Seq profiling of human developing kidney 22.1
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 22.09
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 22.09
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 22.01
Retinoic acid suppresses MYB in adenoid cystic carcinoma 22.01
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 21.98
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 21.96
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 21.96
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 21.95
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 21.83
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 21.81
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 21.81
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 21.66
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 21.62
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 21.6
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 21.48
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 21.23
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 21.2
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 21.16
Genome-wide analysis of Dengue virus 2 infected cells 21.07
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 21.05
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 20.91
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 20.9
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 20.9
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 20.88
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 20.64
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 20.64
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 20.6
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 20.6
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 20.5
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 20.49
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 20.49
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 20.42
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 20.38
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 20.36
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 20.11
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 19.93
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 19.87
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 19.83
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 19.83
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 19.77
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 19.66
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 19.66
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 19.65
NR2F2 study 19.65
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 19.64
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 19.63
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 19.57
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 19.57
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 19.46
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 19.4
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 19.37
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 19.27
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 19.22
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 19.18
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 19.18
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 19.17
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 19.15
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 19.13
Effect of mitochondria deficiency on senescence-associated gene expression 19.08
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 19.05
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 18.94
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 18.86
Gene expression analysis of immortalized human liver progenitor-like cells in culture 18.73
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 18.72
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 18.63
STRIPAK directs PP2A activity to promote oncogenic transformation 18.61
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 18.61
R430: A potent inbibitor of DNA and RNA viruses 18.6
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 18.59
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 18.42
Endothelial gene expression analysis 18.42
Transcriptome analysis of Zika infected neural stem cells 18.4
Zika infected neural stem cells 18.4
RNA-sequencing in irradiated and normal A549 cells. 18.31
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 18.28
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 18.27
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 18.24
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 18.14
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 18.12
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 18.05
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 17.99
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 17.91
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 17.82
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 17.72
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 17.48
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 17.48
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 17.46
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 17.43
The regulartory role of ZCCHC24 in splicing machinery 17.43
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 17.22
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 17.22
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 17.2
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 17.16
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 17.12
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 17.05
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 16.99
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 16.9
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 16.84
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 16.84
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 16.83
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 16.75
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 16.75
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 16.71
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 16.67
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 16.63
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 16.61
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 16.6
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 16.47
Endometrial transcriptome and PGR cistrome in cycling fertile women 16.47
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 16.39
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 16.39
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 16.26
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 16.16
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 16.12
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 16.11
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 16.06
Integrin signaling regulates YAP/TAZ to control skin homeostasis 16.06
RNA-seq of YB5 cells treated with Proscillaridin A 15.98
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 15.92
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 15.92
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 15.88
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 15.87
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 15.8
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 15.8
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 15.77
Tyrosine Kinase Inhibitor Cardiotoxicity 15.77
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 15.7
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 15.67
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 15.25
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 15.19
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 15.17
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 15.1
Systematic discovery of endogenous human ribonucleoprotein complexes 15.07
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 15.02
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 14.94
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 14.87
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 14.86
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 14.78
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 14.76
IRF2 is a master regulator of human keratinocyte stem cell fate 14.76
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 14.62
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 14.62
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 14.57
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 14.46
Paxillin regulates genomic networks in prostate cancer [PC3] 14.39
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 14.38
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 14.21
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 14.09
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 14.06
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 13.88
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 13.88
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 13.82
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 13.74
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 13.67
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 13.59
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 13.59
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 13.45
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 13.36
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 13.36
High-efficiency RNA-based reprogramming of human primary fibroblasts 13.27
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 13.15
CSL RNA-Seq on HKC and SCC cell lines 13.09
CSL 13.09
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 13.05
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 12.93
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 12.9
AR-independent prostate cancer is sustained through FGF signaling 12.86
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 12.81
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 12.81
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 12.7
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 12.57
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 12.31
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 12.26
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 12.05
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 12.01
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 11.93
Gene expression changes upon drug withdrawal (Mel888 cell line) 11.77
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 11.61
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 11.61
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 11.27
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 11.27
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 11.1
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 10.98
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 10.82
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 10.7
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 10.67
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 10.65
A map of gene expression in neutrophil-like cell lines 10.65
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 10.62
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 10.35
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 10.35
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 10.34
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 10.28
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 10.18
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 10.17
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 10.17
10.14
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 9.77
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 9.77
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 9.75
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 9.62
The pioneer factor CEBPA modulates vitamin D signaling 9.62
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 9.34
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 9.34
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 9.3
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 9.3
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 9.17
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 8.93
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 8.92
Effect of from Human Umbilical Vein Endothelial Cells 8.9
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 8.84
Aneuploidy-induced cellular stresses limit autophagic degradation. 8.78
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 8.58
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 8.54
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 8.18
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 8.04
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 8.02
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 7.79
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 7.74
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 7.73
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 7.72
Gene expression profile of multiple myeloma cell lines treated with CB-5083 7.47
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 7.38
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 7.16
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 7.09
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 7.09
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 6.93
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 6.93
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 6.8
6mer seed toxicity in tumour suppressive microRNAs 6.6
Transcriptomic analysis of ERR alpha orphan nuclear receptor 6.59
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 6.57
Tpl-2 and MEK small molecule inhibitors 6.44
Tpl-2 small molecule project 6.44
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 6.37
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 6.37
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 6.29
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 6.28
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 6.11
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 6.05
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 5.51
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 5.26
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 5.25
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 5.24
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 4.88
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 4.88
RNA-Seq in PWS iPSC-derived neurons 4.88
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 4.77
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 4.73
Entrectinib Resistance in a Neuroblastoma Xenograft Model 4.65
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 4.63
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 4.54
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 4.45
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 4.44
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 4.42
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 4.22
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 3.99
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 3.91
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 3.84
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  3.8
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 3.64
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 3.64
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 3.62
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 3.61
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 3.5
ARID1A and ARID1B loss in HCT116 cells 3.45
Gene expression profile of CRC-derived HILEC 3.38
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 3.29
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 3.29
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 3.29
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 2.99
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 2.94
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 2.94
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 2.81
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 2.48
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 2.43
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 2.38
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 2.35
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 2.35
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 2.28
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 2.28
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 2.24
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 2.24
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 2.0
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 1.99
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 1.98
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.78
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 1.65
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 1.57
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 1.48
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 1.46
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 1.28
6mer seed toxicity in viral microRNAs 1.27
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 1.17
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 1.13
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 0.94
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.94
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.89
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.69
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 0.65
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 0.64
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.63
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.6
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.52
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 0.33
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 0.31
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.3


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation